Glucagon-like peptide-1 represents a compelling advance in our control landscape . Originally intended to address diabetes , this class of therapies have revealed considerable ability to encourage fat loss and improve overall fitness. Scientists are now studying their role in addressing excess weight in individuals who don’t have a diabetes diag